Considering HuR’s participation in COPD pathogenesis and its interaction with eosinophils, we hypothesized that there could be different mRNA expression patterns for the ELAVL1 gene in patients with eosinophilic COPD compared to those with non-eosinophilic COPD. This evidence concerns the gene ELAVL1 and chronic obstructive pulmonary disease.